Dr. Ilya Tsimafeyeu is an internationally renowned expert and leading specialist in the treatment of kidney cancer. With extensive experience and a distinguished career, Dr. Tsimafeyeu has made significant contributions to the field of oncology.
Over the years, Dr. Tsimafeyeu has been an integral part of numerous well known organizations. He has served on the expert councils and organizing committees of the Kidney Cancer Association (USA), Kidney Cancer Research Bureau (Russia), Kidney Cancer Patient League (Russia-Belarus-Ukraine), VHL Alliance (USA), and the International Kidney Cancer Coalition (IKCC). His leadership roles include serving as the director of the Institute of Oncology at Hadassah Medical Moscow and co-founding the Russian Society of Clinical Oncology, where he was the first director.
Dr. Tsimafeyeu is also a dedicated educator and active participant in the global oncology community. He is a faculty member of the College of the European School of Oncology (ESCO, Italy) and serves on the Central and Eastern Europe Regional Council of the American Society of Clinical Oncology (ASCO, USA). Additionally, he contributes his expertise as an editorial board member for the Kidney Cancer Journal (USA) and OncoDaily, an international cancer news platform.
His exceptional work in oncology has earned him prestigious awards, including the ASCO Merit Award, ASCO IDEA Award, and the Prix Galien Award. Dr. Tsimafeyeu is deeply involved in drug development and clinical trials, continually advancing the field and improving patient outcomes.
With a commitment to excellence and a passion for innovation, Dr. Ilya Tsimafeyeu remains at the forefront of kidney cancer treatment and research, dedicated to improving the lives of patients worldwide.
Languages: English, Russian
The goal of the International Telemedicine Project STOONCO - Science & Technology in Oncology - is to provide rapid assistance to cancer patients from different countries in accordance with international guidelines. By leveraging the latest advancements in telehealth, STOONCO aims to ensure that patients receive timely and accurate medical advice, regardless of their geographical location.
This innovative project connects patients with top oncologists and healthcare professionals worldwide, facilitating expert consultations and second opinions without the need for travel. STOONCO utilizes state-of-the-art technology to create a seamless communication platform, allowing for the secure sharing of medical records, imaging, and other critical information.
The project is designed to bridge the gap between patients and cutting-edge cancer treatments, making high-quality care accessible to everyone. By adhering to international guidelines, STOONCO ensures that all medical advice and treatment plans are based on the latest research and best practices in oncology.
In addition to providing direct patient care, STOONCO focuses on education and collaboration among healthcare providers. The project offers resources and training to medical professionals, promoting knowledge sharing and the implementation of standardized treatment protocols.
Through its comprehensive approach, the International Telemedicine Project STOONCO is dedicated to improving cancer care outcomes and supporting patients throughout their journey, no matter where they are in the world.
| Learn more |
